GUANGZHOU, China, April 14, 2026 /PRNewswire/ -- Focusing on Advanced Manufacturing, Phase 1 of the 139th Canton Fair is set to…
SHANGHAI, April 10, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the first cohort of healthy…
DUBAI, United Arab Emirates, April 04, 2026 (GLOBE NEWSWIRE) -- As the crypto market looks ahead to 2026, $LOL is…
Appointment of Vikas Chawla builds on significant growth with nearly 5,000 rooms added in 2025 to Hyatt's India and Southwest…
BENGALURU, India, March 30, 2026 /PRNewswire/ -- Tejas Networks (BSE: 540595) (NSE: TEJASNET) today announced that the company has reached a…
Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue…
March 28, 2026 15:00 ET | Source: Roivant Sciences The results of the Phase 3 VALOR trial were published in…
March 27, 2026 10:30 ET | Source: Celldex Therapeutics, Inc. - Improvements seen across all six DLQI Domains indicating broad,…
March 18, 2026 19:34 ET | Source: Vaxcyte, Inc. Based on the Strength of Unprecedented Results from the Positive Phase…
SAN CARLOS, Calif., March 14, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion,” or the “Company”) (Nasdaq: BMEA),…